Form D · Other Investment Fund

Bioverge Funds, EnClear Therapies II, a series of Bioverge Funds II, LLC

Salt Lake City, UT · CIK 0001786499

Offering snapshot reported Feb 6, 2020 · SEC filing

Reported sold
$167K
Offering amount: $167K
Investors reported
26
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Nov 12, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$83.3K$167KNov 13, 2019: $153,980.00Nov 13, 2019Feb 6, 2020: $166,680.00Feb 6, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$153,980 → $166,680
  • Reported investors24 → 26

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 6, 2020Amendment$166,680$12,700vs Nov 13, 201926SEC filing
Nov 13, 2019Initial$153,980No comparison24SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C.1
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-353256

Source: Form D, filed Feb 6, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Llc Lp Assure Fund Management Ii Director
Jeremy Llc Neilson Executive
Richard Llc Thoms Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
6510 South Millrock Drive Suite 400
Salt Lake City, UT, 84121